DE68909254D1 - Heparinbindende Gehirnmitogene. - Google Patents

Heparinbindende Gehirnmitogene.

Info

Publication number
DE68909254D1
DE68909254D1 DE89101187T DE68909254T DE68909254D1 DE 68909254 D1 DE68909254 D1 DE 68909254D1 DE 89101187 T DE89101187 T DE 89101187T DE 68909254 T DE68909254 T DE 68909254T DE 68909254 D1 DE68909254 D1 DE 68909254D1
Authority
DE
Germany
Prior art keywords
mitogens
heparin
brain
hbbms
promotion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE89101187T
Other languages
English (en)
Other versions
DE68909254T2 (de
Inventor
Peter Bohlen
Peter Gautschi-Sova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DE68909254D1 publication Critical patent/DE68909254D1/de
Publication of DE68909254T2 publication Critical patent/DE68909254T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE89101187T 1988-01-25 1989-01-24 Heparinbindende Gehirnmitogene. Expired - Lifetime DE68909254T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14783588A 1988-01-25 1988-01-25

Publications (2)

Publication Number Publication Date
DE68909254D1 true DE68909254D1 (de) 1993-10-28
DE68909254T2 DE68909254T2 (de) 1994-04-28

Family

ID=22523098

Family Applications (1)

Application Number Title Priority Date Filing Date
DE89101187T Expired - Lifetime DE68909254T2 (de) 1988-01-25 1989-01-24 Heparinbindende Gehirnmitogene.

Country Status (9)

Country Link
EP (1) EP0326075B1 (de)
JP (1) JPH01308300A (de)
AT (1) ATE94882T1 (de)
AU (1) AU624803B2 (de)
DE (1) DE68909254T2 (de)
DK (1) DK29889A (de)
ES (1) ES2058350T3 (de)
FI (1) FI890342A (de)
NO (1) NO175594C (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8801426D0 (sv) * 1988-04-15 1988-04-15 Ulf Rothman Forfarande och medel for blodbehandling
US5126323A (en) * 1989-11-16 1992-06-30 Genetics Institute, Inc. Homogeneous purified k-fgf and compositions containing the same
US6448381B1 (en) 1990-01-08 2002-09-10 Barnes-Jewish Hospital DNA encoding heparin-binding growth factor
DE69126563T2 (de) * 1990-04-12 1998-02-05 Ebewe Arzneimittel Verwendung einer Mischung von Peptiden and Aminosäuren für die Prophylaxis oder Behandlung von Dementia
FR2665448A1 (fr) * 1990-08-01 1992-02-07 Paris Val De Marne Universite Procede d'obtention d'un peptide ayant une activite facteur de croissance, produit obtenu et son application comme medicament.
US5210026A (en) * 1990-08-20 1993-05-11 American Cyanamid Company Human mk gene and method of expression
US6511823B1 (en) * 1990-08-20 2003-01-28 American Cyanamid Corporation Heparin binding neurotrophic factor gene sequence
EP0535336A3 (en) * 1991-09-30 1993-05-19 American Cyanamid Company Mk protein as cell growth inhibitor
EP0535337A3 (en) * 1991-09-30 1993-05-19 American Cyanamid Company Cell growth inhibiting activities of heparin binding neurite-outgrowth promoting factor
FI980032A0 (fi) * 1998-01-09 1998-01-09 Heikki Matti Eemeli Rauvala Ny anvaendning av en heparin bindande, med tillvaext foerknippad molekyl
US6364912B1 (en) * 1999-09-17 2002-04-02 Depuy Orthopeaedics, Inc. Pleiotrophin-based compositions for enhancing connective tissue repair
US7888485B2 (en) 2003-03-26 2011-02-15 Georgetown University Anti-pleiotrophin antibodies and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0248088A4 (de) * 1985-11-22 1988-05-03 Teijin Ltd Vaskularisierungsfaktor und herstellung.
EP0241136A3 (de) * 1986-03-07 1989-12-27 The President And Fellows Of Harvard College Humaner, Klasse 1 Heparin bindender, Wachstumsfaktor
CA2005600A1 (en) * 1988-12-20 1990-06-20 Cal-Henrik Heldin Endothelial cell growth factor

Also Published As

Publication number Publication date
NO175594B (no) 1994-07-25
DE68909254T2 (de) 1994-04-28
DK29889A (da) 1989-07-26
ATE94882T1 (de) 1993-10-15
NO890295D0 (no) 1989-01-24
AU624803B2 (en) 1992-06-25
NO890295L (no) 1989-07-26
ES2058350T3 (es) 1994-11-01
EP0326075A3 (en) 1989-10-18
EP0326075B1 (de) 1993-09-22
JPH01308300A (ja) 1989-12-12
FI890342A0 (fi) 1989-01-24
EP0326075A2 (de) 1989-08-02
DK29889D0 (da) 1989-01-24
NO175594C (no) 1994-11-02
FI890342A (fi) 1989-07-26
AU2873789A (en) 1989-07-27

Similar Documents

Publication Publication Date Title
IT1214505B (it) Procedimento per la preparazione di collageno e prodotti cosi'ottenuto.
DE69727589D1 (de) Mutanten des KERATINOCYTEN-WACHSTUMSFAKTOR-2 (KGF-2 ODER FIBROBLASTENWACHSTUMSFAKTOR-12,FGF-12)
DK0429570T3 (da) Osteoinducerende præparater
DE68909254D1 (de) Heparinbindende Gehirnmitogene.
DK0386793T3 (da) 1alfa-hydroxyvitamin D2 epimer og derivater heraf
ES2042742T3 (es) Procedimiento para preparar furanonas antiinflamatorias.
DE69130497T2 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
EP0548123A4 (en) Anti-inflammatory factor, method of isolation, and use
ATE89728T1 (de) Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen.
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
DE68903907T2 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
EP0241136A3 (de) Humaner, Klasse 1 Heparin bindender, Wachstumsfaktor
IT1225483B (it) Protesi ortopedica, particolarmente per la testa del femore.
ATE120799T1 (de) Mutein von hst-1 und seine herstellung.
DE68924545D1 (de) Verwendung von Chinolizin- und Chinolizinon-Derivaten zur Herstellung von Arzneimitteln.
EP0635010A1 (de) Neue kardioprotektive wirkstoffe.
DE58906618D1 (de) Strobilurinderivate, ihre Herstellung und Verwendung.
DE3784308T2 (de) Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis.
DE59504374D1 (de) Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen
RU93037867A (ru) Способ лечения длительно незаживающих ран и трофических язв кожных покровов

Legal Events

Date Code Title Description
8364 No opposition during term of opposition